Credits Available: 4.75 hours of AMA PRA Category 1 Credit™; ABIM MOC

Description: Despite significant advancements in treatment, multiple myeloma remains an incurable disease, and nearly all patients experience relapse, often requiring increasingly complex therapeutic strategies.

With the rapid expansion of treatment options, particularly novel targeted therapies such as GPRC5D-directed approaches, the landscape of relapsed/refractory multiple myeloma (RRMM) management is evolving at an unprecedented pace. While these agents offer deep and durable remissions, their integration into clinical practice presents challenges in sequencing, toxicity management, and multidisciplinary coordination.

This educational initiative is designed to empower clinicians with the latest insights on GPRC5D-targeted therapies, facilitate the exchange of real-world clinical experience, and provide actionable strategies for optimizing patient outcomes. Through interactive discussions and expert-led guidance, participants will gain practical knowledge to navigate the complexities of RRMM treatment while fostering collaborative networks to enhance long-term patient care.

Join us to stay at the forefront of innovation in multiple myeloma management and elevate your clinical practice.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Nurse, Physician Associate/Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Sita Bhatt

Boston Medical Center
Pharmacy Clinical Specialist- Hematology/Oncology, Clinical Coordinator

Sita Bhatt, PharmD, BCOP is a pharmacy specialist at Boston Medical Center in Boston, MA. She received her Doctor of Pharmacy degree from the University of Florida in Gainesville, FL. She went on to complete an ASHP-accredited PGY1 pharmacy practice residency at Cleveland Clinic Florida in Ft. Lauderdale, FL, followed by a PGY2 hematology/oncology residency at Boston Medical Center.
Following residency, Dr. Bhatt remained at Boston Medical Center, where she practices in both inpatient and outpatient oncology settings. She is a board-certified oncology pharmacist with over three years of experience managing cancer patients across diverse populations.
Dr. Bhatt currently serves as the Residency Program Director for the PGY2 Hematology/Oncology Pharmacy Residency and is the Clinical Coordinator for Hematology/Oncology at Boston Medical Center. In addition, she is the thread Co-Director of Hematology/Oncology at the Boston University School of Medicine, where she also holds the title of Instructor of Medicine.